Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development.
Youn-Hee ChoiPublished in: Development & reproduction (2023)
Development of hepatocellular carcinoma (HCC) is driven by a multistep and long-term process. Because current therapeutic strategies are limited for HCC patients, there are increasing demands for understanding of immunotherapy, which has made technological and conceptual innovations in the treatment of cancer. Here, I discuss HCC immunotherapy in the view of interaction between liver resident cells and immune cells.
Keyphrases
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- induced apoptosis
- stem cells
- prognostic factors
- papillary thyroid
- peritoneal dialysis
- patient safety
- cell cycle arrest
- squamous cell carcinoma
- squamous cell
- patient reported outcomes
- cell death
- quality improvement
- young adults
- endoplasmic reticulum stress
- oxidative stress
- patient reported